Search Results (267)
Click the Why column to see why an item matched the search.
Match | Type | Why |
---|
Kindler, Hedy | Person |
Why?
|
Armato, Samuel G. | Person |
Why?
|
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. | Academic Article |
Why?
|
Husain, Aliya | Person |
Why?
|
Further validation of SV40-like DNA in human pleural mesotheliomas. | Academic Article |
Why?
|
Molecular analyses, morphology and immunohistochemistry together differentiate pleural synovial sarcomas from mesotheliomas: clinical implications. | Academic Article |
Why?
|
Salgia, Ravi | Person |
Why?
|
Human mesotheliomas contain the simian virus-40 regulatory region and large tumor antigen DNA sequences. | Academic Article |
Why?
|
EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach. | Academic Article |
Why?
|
Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. | Academic Article |
Why?
|
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma. | Academic Article |
Why?
|
The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma. | Academic Article |
Why?
|
The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma. | Academic Article |
Why?
|
Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation. | Academic Article |
Why?
|
Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative Chemotherapy. | Academic Article |
Why?
|